achieving haematological but not cytogenetic remission. She had no HLA-identical siblings. In March 1996, she developed bone pain, increasing hepatosplenomegaly, and A 14-year-old girl from the UK underwent volunteer unrelated donor bone marrow transplant (VUD BMT) a rising white cell count. Her peripheral blood film showed 10% blasts, although cytogenetic analysis remained for accelerated phase chronic myeloid leukaemia. On day +40 she became febrile, and peripheral blood unchanged. She was treated with 'DAT 3+10', and underwent splenectomy, followed by allogeneic bone marsmears demonstrated a 1% Plasmodium vivax parasitaemia. Although she had never been outside the UK, her row transplantation from a fully matched volunteer unrelated donor in September 1996. Conditioning was with male donor had documented Plasmodium vivax infection during a vacation in Papua New Guinea. Following cyclophosphamide (120 mg/kg), etoposide (50 mg/kg), and fractionated total body irradiation (1440 cGy) with lung appropriate treatment, he had been asymptomatic for 11 months before marrow harvesting. This is the first shielding. GVHD prophylaxis was with cyclosporin A and methotrexate. In addition she received Campath 1H case report of malarial transmission by VUD BMT, and illustrates the potential problem of recrudescence of lat-(5 mg/day) from day −5 to day +5. The unrelated donor was a German male, and the total cell dose received was ent, dormant forms of Plasmodium vivax infection following transplantation into an immuno-compromised 5.2 × 10 8
/kg. Her post-transplant course was complicated by marked recipient. Even after appropriate therapy, malarial infection should be included in the differential diagnosis mucositis, confluent oesphagitis necessitating total parenteral nutrition, and mild graft-versus-host disease of gut for all post-transplant febrile episodes. Keywords: Plasmodium vivax; volunteer unrelated bone confirmed by endoscopic biopsy on day +25. Throughout this period she remained afebrile on prophylactic antibiotics marrow transplantation only. Neutrophil engraftment occurred on day +17. Serial DEAFF (detection of early antigenic fluorescent foci) testing remained negative throughout, and routine ganciclovir Bone marrow transplantation from a volunteer unrelated prophylaxis was commenced on day +28. On day +40, she donor (VUD) is associated with an increased risk of infecbecame unwell with pyrexia of 40°C and rigors. She tious complications when compared to sibling allogeneic described no focal symptoms and physical examination was BMT.
1 However, malaria complicating BMT is extremely unremarkable. Oxygen saturation and chest X-ray were unusual. We describe a case of Plasmodium vivax infection within normal limits. However, examination of her perioccurring as a complication of volunteer unrelated BMT.
pheral blood film demonstrated intraerythrocytic parasites characteristic of Plasmodium vivax, and an estimated parasitaemia of 1%.
Case report
This patient had no previous history of malaria and had never travelled outside the UK. She was commenced on A 14-year-old girl was referred to our institution in July treatment with chloroquine, and became afebrile within 1995 with chronic phase chronic myeloid leukaemia 24 h. Chloroquine was continued for 7 days in total, fol-(CML). She had first been diagnosed in September 1988.
lowed by a 3-week course of primaquine to eradicate potenCytogenetics demonstrated 46XX inv(22)(p11q11), and tial exoerythrocytic liver cycling. She was discharged on molecular analysis showed BCR-ABL rearrangement. She day +69, and currently remains well in complete remission was initially treated with interferon-␣ and hydroxyurea, at day +186 (FBC: Hb 13.2; WCC 7.8; platelets 719). Subsequent investigation revealed that the volunteer donor had spent a vacation in Papua New Guinea in June Correspondence: Dr J O'Donnell, Department of Haematology, Ham-was incomplete. In October 1995 he was admitted to hospieral blood films. Despite this precaution, our patient developed a sudden dramatic parasitaemia which was only tal with fever, and a diagnosis of tertian malaria was made. No typing of malarial parasites was available. After treatapparent when she became pyrexial on day +40 post-BMT. It is possible that the previous splenectomy in our patient ment with quinine, followed by halofantrine for 7 days, he made an uneventful recovery. However, in November 1995 may in part be responsible for the sudden dramatic parasitaemia. he again developed a febrile illness and was readmitted. His blood film again demonstrated 1-2% parasitaemia. On This case raises the question of how to prevent malarial transmission in the context of VUD BMT. In particular, the this occasion he was managed with halofantrine and tetracycline. Since then he had experienced no further malariaproblem of donors at high risk of latent liver carriage of Plasmodium vivax or ovale must be addressed. Current reclike symptoms. He has now been advised to undergo a 3-week course of primaquine to eradicate any residual ommendations are that all high-risk donors should be screened using thick and thin films, and malarial antibody parasites.
titres. If any of these are positive, appropriate treatment is required prior to marrow harvesting. However, even if these donor screening procedures prove unremarkable, as in our Discussion patient, it is vital that there is close communication between the physicians involved in donor assessment, and the team Malaria as a complication of BMT is extremely unusual.
dealing with the VUD BMT recipient. Hence, relevant There are two case reports of Plasmodium falciparum transinformation regarding donor risk factors will serve to mission following sibling allogeneic transplant, and one reinforce the need for the inclusion of malarial reactivation report of Plasmodium vivax recrudescence after an autologin the differential diagnosis of any post-transplant febrile ous transplant.
2-4 However, there are no previous reports episodes. Also, subsequent choice of treatment in each case, of malaria after VUD marrow transplantation. This is surcan then be guided by the travel history of the marrow prising in view of the fact that nosocomial malarial transdonor, with appropriate consideration of likely patterns of mission is well recognised. It can follow blood transfusion drug resistance. and needle-stick injuries, and more recently, transmission of Plasmodium falciparum via the use of a single syringe on heparin locks has been described. 5 Malaria transmission References has also been reported following both renal and cardiac transplantation. 
